Skip to main content

Responding to Traumatized Children: a Psychopharmacological Focused Treatment Approach

  • Chapter
Book cover Responses to Traumatized Children
  • 126 Accesses

Abstract

This chapter will describe the current pharmacological treatment of Post-Traumatic Stress Disorder (PTSD) and the classes of pharmacologic agents used in such treatment. However, pharmacotherapy for PTSD with co-occurring psychiatric disorders will also be highlighted and discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Baker, D. G., West, S. A., Nicholson, W. E. et al. (1999) ‘Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with posttraumatic stress disorder’. American Journal of Psychiatry, 156: 585–8.

    Google Scholar 

  • Berlant, J. and van Kammen, D. P. (2002) ‘Open-label topiramate as primary or adjunctive therapy in chronic civilian posttraumatic stress disorder: a preliminary report’. Journal of Clinical Psychiatry, 63: 15–20.

    Article  Google Scholar 

  • Brady, K., Pearlstein, T., Asnis, G. M. et al. (2000) ‘Efficacy and safety of sertraline treatment of posttraumatic stress disorder: a randomized controlled trial’. Journal of the American Medical Association, 283: 1837–44.

    Article  Google Scholar 

  • Braun, P., Greenberg, D., Dasberg, H. et al. (1990) ‘Core symptoms of post-traumatic stress disorder unimproved by alprazolam treatment’. Journal of Clinical Psychiatry, 51: 236–8.

    Google Scholar 

  • Butterfield, M. I., Becker, M. E., Connor, K. M. et al. (2001) ‘Olanzapine in the treatment of post-traumatic stress disorder: a pilot study’. International Clinical Psychopharmacology, 16: 197–203.

    Article  Google Scholar 

  • Canive, J. M., Clark, R. D., Calais, L. A. et al. (1998) ‘Bupropion treatment in veterans with posttraumatic stress disorder: an open study’. Journal of Clinical Psychopharmacology, 18: 379–83.

    Article  Google Scholar 

  • Davidson, J. R., Kudler, H. S., Smith, R. et al. (1990) ‘Treatment of posttraumatic stress disorder with amitriptyline and placebo’. Archives of General Psychiatry, 47: 259–66.

    Article  Google Scholar 

  • Davidson, J. R., Weisler, R. H., Butterfield, M. I. et al. (2003) ‘Mirtazapine vs placebo in posttraumatic stress disorder: a pilot trial’. Biological Psychiatry, 53: 188–91.

    Article  Google Scholar 

  • Duffy, J. D. and Malloy, P. F. (1994) ‘Efficacy of buspirone in the treatment of posttraumatic stress disorder: an open trial’. Annals of Clinical Psychiatry, 6: 33–7.

    Article  Google Scholar 

  • Famularo, R., Kinscherff, R. and Fenton, T. (1988) ‘Propranolol treatment for childhood posttraumatic stress disorder, acute type: a pilot study’. American Journal of Diseases of Children, 142: 1244–7.

    Article  Google Scholar 

  • Fesler, F. A. (1991) ‘Valproate in combat-related posttraumatic stress disorder’. Journal of Clinical Psychiatry, 52: 361–4.

    Google Scholar 

  • Forster, P. L., Schoenfeld, F. B., Marmar, C. R. et al. (1995) ‘Lithium for irritability in post-traumatic stress disorder’. Journal of Traumatic Stress, 8: 143–9.

    Article  Google Scholar 

  • Frank, J. B., Kosten, T., Giller, E. L. Jr et al. (1988) ‘A randomized clinical trial of phenylzine and imipramine for posttraumatic stress disorder’. American Journal of Psychiatry, 145: 1289–91.

    Article  Google Scholar 

  • Gelpin, E., Bonne, O., Peri, T. et al. (1996) ‘Treatment of recent trauma survivors with benzodiazepines: a prospective study’. Journal of Clinical Psychiatry, 57: 390–4.

    Google Scholar 

  • Goddard, A. W., Woods, S. W., Sholomskas, D. E. et al. (1993) ‘Effects of the serotonin reuptake inhibitor fluvoxamine on yohimbine-induced anxiety in panic disorder’. Psychiatry Research, 48: 119–33.

    Article  Google Scholar 

  • Gregorian, R. S., Golden, K. A., Bache, A. et al. (2002) ‘Antidepressant-induced sexual dysfunction’. Annals of Pharmacotherapy, 36: 1577–89.

    Article  Google Scholar 

  • Grillon, C., Morgan, C. A., Southwick, S. M. et al. (1996) ‘Baseline startle amplitude and prepulse inhibition in Vietnam veterans with posttraumatic stress disorder’. Psychiatry Research, 64: 169–78.

    Article  Google Scholar 

  • Hamner, M. B., Brodrick, P. S. and Labbate, L. A. (2001) ‘Gabapentin in PTSD: a retrospective, clinical series of adjunctive therapy’. Annals of Clinical Psychiatry, 13: 141–6.

    Article  Google Scholar 

  • Hamner, M. B., Deitsch, S. E. and Brodrick, P. S. (2003) ‘Quetiapine treatment in patients with posttraumatic stress disorder: an open adjunctive therapy’. Journal of Clinical Psychopharmacology, 23: 15–20.

    Article  Google Scholar 

  • Harmon, R. J. and Riggs, P. (1996) ‘Clonidine for posttraumatic stress disorder in preschool children’. Journal of the American Academy of Child and Adolescent Psychiatry, 35: 1247–9.

    Article  Google Scholar 

  • Hertzberg, M. A., Butterfield, M. I., Feldman, M. E. et al. (1999) ‘A preliminary study of lamotrigine for the treatment of posttraumatic stress disorder’. Biological Psychiatry, 45: 1226–9.

    Article  Google Scholar 

  • Hertzberg, M. A., Feldman, M. E., Beckham, J. C. et al. (1996) ‘Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design’. Journal of Clinical Psychopharmacology, 16: 294–8.

    Article  Google Scholar 

  • Hidalgo, R., Hertzberg, M. A., Mellman T. et al. (1999) ‘Nefazodone in post-traumatic stress disorder: results from six open-label trials’. International Clinical Psychopharmacology, 14: 61–8.

    Article  Google Scholar 

  • Horrigan, J. P. and Barnhill, L. J. (1996) ‘The suppression of nightmares with guanfacine’. Journal of Clinical Psychiatry, 57: 371.

    Google Scholar 

  • Kaplan, H. I. and Sadock, B. (1998) Synopsis of Psychiatry, 8th edn. Baltimore: Lippincott Williams & Wilkins.

    Google Scholar 

  • Keck, P. E. Jr, McElroy, S. L. and Friedman, L. M. (1992) ‘Valproate and carbamazepine in the treatment of panic and posttraumatic stress disorders, withdrawal states, and behavioral dyscontrol syndrome’. Journal of Clinical Psychopharmacology, 12: 36S–41S.

    Article  Google Scholar 

  • Kinzie, J. D. (1998) ‘Therapeutic approaches to traumatized Cambodian refugees’. Journal of Traumatic Stress, 2: 75–91.

    Article  Google Scholar 

  • Kinzie, J. D. and Leung, P. (1989) ‘Clonidine in Cambodian patients with posttraumatic stress disorder’. Journal of Nervous and Mental Disease, 177: 546–50.

    Article  Google Scholar 

  • Kitchner, I. and Greenstein, R. (1983) ‘Low-dose lithium carbonate in the treatment of posttraumatic stress disorder’. Hospital and Community Psychiatry, 34: 683–91.

    Google Scholar 

  • Kolb, L. C., Burris, B. C. and Griffiths, S. (1984) ‘Propranolol and clonidine in the treatment of the chronic post traumatic stress disorders of war’, in Post-Traumatic Stress Disorder: Psychological and Biological Sequelae, ed, B. A. Van der Kolk. Washington DC: American Psychiatric Press.

    Google Scholar 

  • Krashin, D. and Oates, E. W. (1999) ‘Risperidone as an adjunct therapy for post-traumatic stress disorder’. Military Medicine, 164: 605–6.

    Google Scholar 

  • Lipper, S., Davidson, J. R., Grady, T. A. et al. (1986) ‘Preliminary study of carbamazepine in post-traumatic stress disorder’. Psychosomatics, 27: 849–54.

    Article  Google Scholar 

  • Marmar, C. R., Schoenfeld, F. B., Weiss, D. S. et al. (1996) ‘Open trial of fluvoxamine treatment for combat-related posttraumatic stress disorder’. Journal of Clinical Psychiatry, 57(suppl. 8): 66–72.

    Google Scholar 

  • Marshall, R. D., Beebe, K. L., Oldham, M. et al. (2001) ‘Efficacy and safety of paroxetine treatment for chronic PTSD: a fixed-dose, placebo-controlled study’. American Journal of Psychiatry, 158: 1982–8.

    Article  Google Scholar 

  • Mellman, T. A., David, D. and Barza, L. (1999) ‘Nefazodone treatment and dream reports in chronic PTSD’. Depression and Anxiety, 9: 146–8.

    Article  Google Scholar 

  • Monnelly, E. P., Ciraulo, D. A., Knapp, C. et al. (2003) ‘Low-dose risperidone as adjunctive therapy for irritable aggression in posttraumatic stress disorder’. Journal of Clinical Psychopharmacology, 23: 193–6.

    Article  Google Scholar 

  • Neal, L. A., Shapland, W. and Fox, C. (1997) ‘An open trial of moclobemide in the treatment of post-traumatic stress disorder’. International Clinical Psychopharmacology, 12: 231–7.

    Article  Google Scholar 

  • Orr, S. P., Metzger, L. J., Lasko, N. B. et al. (2000) ‘De novo conditioning in trauma-exposed individuals with and without posttraumatic stress disorder’. Journal of Abnormal Psychology, 109: 290–8.

    Article  Google Scholar 

  • Petty, F., Brannan, S., Casada, J. et al. (2001) ‘Olanzapine treatment for post-traumatic stress disorder: an open-label study’. International Clinical Psychopharmacology, 16: 331–7.

    Article  Google Scholar 

  • Pitman, R. K. (1989) ‘Post-traumatic stress disorder, hormones, and memory’. Biological Psychiatry, 26: 221–3.

    Article  Google Scholar 

  • Pitman, R. K., Sanders, K. M., Zusman, R. M. et al. (2002) ‘Pilot study of secondary prevention of posttraumatic stress disorder with propranolol’. Biological Psychiatry, 51: 189–92.

    Article  Google Scholar 

  • Raskind, M. A., Peskind, E. R., Kanter, E. D. et al. (2003) ‘Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo controlled study’. American Journal of Psychiatry, 160: 371–3.

    Article  Google Scholar 

  • Reist, C., Kauffmann, C. D., Haier, R. J. et al. (1989) ‘A controlled trial of desipramine in 18 men with posttraumatic stress disorder’. American Journal of Psychiatry, 146: 513–16.

    Article  Google Scholar 

  • Risse, S. C., Whitters, A., Burke, J. et al. (1990) ‘Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder’. Journal of Clinical Psychiatry, 51: 206–9.

    Google Scholar 

  • Schoenfeld, F., Marmar, C. and Neylan, T. (2004) ‘Current concepts in pharmacotherapy for posttraumatic stress disorder’. Psychiatric Services, 55: 519–31.

    Article  Google Scholar 

  • Seedat, S., Stein, D. J., Ziervogel, C. et al. (2002) ‘Comparison of response to a selective serotonin reuptake inhibitor in children, adolescents, and adults with posttraumatic stress disorder’. Journal of Child and Adolescent Psychopharmacology, 12: 37–46.

    Article  Google Scholar 

  • Smajkic, A., Weine, S., Duric-Bijedic, Z. et al. (2001) ‘Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms’. Journal of Traumatic Stress, 14: 445–52.

    Article  Google Scholar 

  • Sokolski, K. N., Denson, T. F., Lee, R. T. et al. (2003) ‘Quetiapine for treatment of refractory symptoms of combat-related post-traumatic stress disorder’. Military Medicine, 168: 486–9.

    Google Scholar 

  • Southwick, S., Paige, S., Morgan, C. et al. (1999) ‘Neurotransmitter alterations in PTSD: catecholamines and serotonin’. Seminars in Clinical Neuropsychiatry, 4: 242–8.

    Google Scholar 

  • Southwick, S. M., Yehuda, R., Giller, E. et al. (1994) ‘Use of tricyclics and monoamine oxidase inhibitors in the treatment of post traumatic stress disorder: a quantitative review’, in Catecholamine Function in Post-Traumatic Stress Disorder: Emerging Concepts, ed. M. M Murburg. Washington DC: American Psychiatric Press.

    Google Scholar 

  • Stein, M. B., Kline, N. A. and Matloff, J. L. (2002) ‘Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study’. American Journal of Psychiatry, 159: 1777–9.

    Article  Google Scholar 

  • Vaiva, G., Docrocq, F., Jezequel, K. et al. (1994) ‘Immediate treatment with proparanolol decreases posttraumatic stress disorder two months after trauma’. Biological Psychiatry, 54: 947–9.

    Article  Google Scholar 

  • Van der Kolk, B. A. (1991) ‘Psychopharmacological issues in posttraumatic stress disorder’. American Journal of Psychiatry, 148: 1086–7.

    Google Scholar 

  • Van der Kolk, B. A. Dreyfuss, D., Michaels, M. et al. (1994) ‘Fluoxetine in post-traumatic stress disorder’. Journal of Clinical Psychiatry, 55: 517–22.

    Google Scholar 

  • Wang, S., Mason, J., Southwick, S. et al. (1995) ‘Relationships between thyroid hormones and symptoms in combat-related posttraumatic stress disorder’. Psychosomatic Medicine, 57: 398–402.

    Article  Google Scholar 

  • Yehuda, R., Southwick, S. M., Krystal, J. H. et al. (1993) ‘Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder’. American Journal of Psychiatry, 150: 83–6.

    Article  Google Scholar 

  • Zohar, J., Amital, D., Miodownik, C. et al. (2002) ‘Double-blind placebo-controlled pilot study of sertraline in military veterans with posttraumatic stress disorder’. Journal of Clinical Psychopharmacology, 22: 190–5.

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Copyright information

© 2007 Iyad Khreis and Rula Khreis

About this chapter

Cite this chapter

Khreis, I., Khreis, R. (2007). Responding to Traumatized Children: a Psychopharmacological Focused Treatment Approach. In: Hosin, A.A. (eds) Responses to Traumatized Children. Palgrave Macmillan, London. https://doi.org/10.1057/9780230625808_7

Download citation

Publish with us

Policies and ethics